Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/12/1999CA2316860A1 Three-dimensional structures and models of fc receptors and uses thereof
08/12/1999CA2310041A1 Lipid mixtures and their use
08/12/1999CA2286174A1 Benzyloxy prodigiosine compounds
08/11/1999EP0934954A1 Branched cyclodextrin clathrate compound of hinokitiols and composition containing the same
08/11/1999EP0934949A1 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives
08/11/1999EP0934944A1 7-bromo- and 7,7-dibromo-cepham and cephem derivatives and their use as protease inhibitors
08/11/1999EP0934942A1 Novel beta-lactam compounds and process for preparing the same
08/11/1999EP0934939A1 Neuraminic acid compounds
08/11/1999EP0934937A1 Azole derivatives as superoxide radical inhibitor
08/11/1999EP0934934A2 Methods of preparing substituted 3-phenyl- and 3-pyridyl-4(3H)-quinazolinones and atropisomers thereof
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934928A1 Cyclic amine derivatives
08/11/1999EP0934745A1 Use of androsterone derivatives for inhibiting DNA binding of ap-1 and airway smooth muscle proliferation
08/11/1999EP0934744A1 Nitroglycerin preparation for treatment of erectile dysfunction
08/11/1999EP0934742A2 High glycerin containing anti-microbial cleansers
08/11/1999EP0934593A1 Electrically conductive adhesive hydrogels
08/11/1999EP0934531A1 Diagnosis of spongiform encephalopathy
08/11/1999EP0934424A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
08/11/1999EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF
08/11/1999EP0934409A2 Diabetes-mediating proteins and therapeutic uses thereof
08/11/1999EP0934404A1 Inhibition of proliferation of cells
08/11/1999EP0934352A1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
08/11/1999EP0934341A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
08/11/1999EP0934340A1 Novel compounds
08/11/1999EP0934336A1 Novel compounds
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934334A1 8(9)-dehydroestradiol derivatives
08/11/1999EP0934331A2 Mirror-symmetrical selection and evolution of nucleic acids
08/11/1999EP0934326A1 Substituted aminoalkane phosphonic acids
08/11/1999EP0934325A1 Tetraphosphonate bicyclic trisanhydrides
08/11/1999EP0934321A1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/11/1999EP0934320A1 Naphthyridine derivatives
08/11/1999EP0934319A1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS
08/11/1999EP0934318A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999EP0934317A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999EP0934316A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
08/11/1999EP0934314A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934313A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934312A1 1,4-disubstituted piperazines
08/11/1999EP0934311A2 New heterocyclylmethyl-substituted pyrazol derivates
08/11/1999EP0934310A1 THIO ACID DERIVED MONOCYCLIC $i(N)-HETEROCYCLICS AS ANTICOAGULANTS
08/11/1999EP0934309A1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
08/11/1999EP0934308A1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934306A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934305A1 Integrin antagonists
08/11/1999EP0934304A1 2-pyrimidineamine derivatives and processes for their preparation
08/11/1999EP0934303A2 Compounds useful for inhibition of farnesyl protein transferase
08/11/1999EP0934301A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934299A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934298A1 NOVEL (+)-ENANTIOMERS OF $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934295A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics
08/11/1999EP0934293A1 Novel compounds and compositions for treating diseases associated with tryptase activity
08/11/1999EP0934292A1 Metalloproteinase inhibitors
08/11/1999EP0934291A1 Protease inhibitors
08/11/1999EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
08/11/1999EP0934288A1 Oxadiazoles, processes for their preparation and their use as medicaments
08/11/1999EP0934287A1 Heterocyclic esters and amides
08/11/1999EP0934286A1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
08/11/1999EP0934282A1 1,4-benzodiazepinones and their uses as cck antagonists
08/11/1999EP0934281A1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators
08/11/1999EP0934280A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
08/11/1999EP0934278A1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
08/11/1999EP0934277A1 Process for the preparation of n- 2-(dimethylamino)ethyl]acridine-4-carboxamide
08/11/1999EP0934276A1 Anthranilic acid derivatives as multi drug resistance modulators
08/11/1999EP0934274A1 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
08/11/1999EP0934273A1 New derivates from piperidine-keto acid, their preparation and use
08/11/1999EP0934271A1 Substituted arylalkylamines as neurokinin antagonists
08/11/1999EP0934270A1 A method of treating cancer
08/11/1999EP0934267A1 $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS
08/11/1999EP0934265A1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
08/11/1999EP0934264A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/11/1999EP0934263A1 Heterocyclic thioesters and ketones
08/11/1999EP0934262A1 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
08/11/1999EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934257A1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones
08/11/1999EP0934249A1 Conformationally restricted polyamines and their use as antineoplastic agents
08/11/1999EP0934080A2 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
08/11/1999EP0934079A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta
08/11/1999EP0934078A2 Permeation enhancers for transdermal drug delivery compositions, devices, and methods
08/11/1999EP0934076A1 Solid phase lipoglycopeptide library, compositions and methods
08/11/1999EP0934075A2 Method for the prevention and treatment of mastitis
08/11/1999EP0934074A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
08/11/1999EP0934071A1 Non-aqueous colonic purgative formulations
08/11/1999EP0934069A1 Method and composition for the treatment of lipid and glucose metabolism disorders
08/11/1999EP0934068A1 Compounds and methods
08/11/1999EP0934067A1 Antimicrobial compositions
08/11/1999EP0934066A1 Il-8 receptor antagonists
08/11/1999EP0934065A1 Pharmaceutical compounds
08/11/1999EP0934064A1 Thrombin inhibitors
08/11/1999EP0934063A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/11/1999EP0934062A1 Antioxidant activity of 3-dehydroshikimates
08/11/1999EP0934061A1 Isobutylgaba and its derivatives for the treatment of pain
08/11/1999EP0934060A1 Dietary supplements
08/11/1999EP0934059A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
08/11/1999EP0934058A2 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
08/11/1999EP0934057A1 Medicinal aerosol formulations of formoterol